Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
224 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (2)

Medical Condition

  • Show all (59)
  • Autoimmune Disorders (2)
  • Blood Disorders (4)
  • Cancer (11)
    • Gastrointestinal (1)
    • Gynecologic Cancer (4)
    • Kidney Cancer (1)
    • Leukemia (2)
    • Skin Cancer (1)
      • (-) Melanoma (1)
    • (-) Solid Tumors (1)
  • Diabetes (1)
  • Gastrointestinal and Digestive Diseases (2)
  • Healthy Volunteers (4)
  • Heart Disease (2)
  • Infectious Disease (4)
  • Neurological Disorders (6)
  • Nutrition (1)
  • Obstetrics & Gynecology (1)
  • Pediatrics (13)
  • Psychiatric Disorders (1)
  • Transplant (7)
Displaying 1 - 2 of 2

Study of TSR-042 (anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Condition: Cancer / Solid Tumors
Investigator: June Hou, MD
Status: Closed
The study drug (TSR-042) in this study is designed to stop cancer from growing by helping your immune system recognize and fight the cancer. The Study Drug is designed to help your immune system by attaching to a protein called PD-1 and stopping one of the signals that keeps your immune sy…
Read More

Study of Nivolumab in Patients with Resected Stage IIB/IIC Melanoma

Condition: Skin Cancer / Melanoma
Investigator: Larisa Geskin, MD
Status: Closed
The purpose of this study is to determine how effective and safe the immune drug Nivolumab is for patients who have newly diagnosed cutaneous melanoma. Nivolumab is an anti-body, a type of human protein, that is being tested to see if it will allow the body's immune system to work against tumor cell…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science